Fatty acid composition, enzyme inhibitory effect, antioxidant and anticancer activity of extract from Saponaria prostrata WILLD. subsp. anatolica HEDGE.


Journal

Bioorganic chemistry
ISSN: 1090-2120
Titre abrégé: Bioorg Chem
Pays: United States
ID NLM: 1303703

Informations de publication

Date de publication:
08 2021
Historique:
received: 03 01 2021
revised: 22 03 2021
accepted: 24 05 2021
pubmed: 6 6 2021
medline: 26 10 2021
entrez: 5 6 2021
Statut: ppublish

Résumé

This study attempts to evaluate the antioxidant, enzyme inhibitory, and anticancer properties as well as fatty acid compositions of endemic Saponaria prostrata WILLD. subsp. anatolica HEDGE. The gas chromatography-mass spectrometry (GC-MS) was used to determine the fatty acid content of methanol: dichloromethane extract from S. prostrata subsp. anatolica (SPA). Enzymatic activity was measured against acetylcholinesterase, butyrylcholinesterase and α-glucosidase. DPPH (2,2-diphenyl-1-picrylhydrazyl) free radical scavenging activity and Ferric reducing antioxidant power assay (FRAP) were conducted to antioxidant properties. The anticancer effect of SPA on human MCF-7 breast cancer and human HCT116 colorectal cancer cell line was evaluated by WST-1 cell viability assay, colony formation assay and wound healing assay. In addition, human VEGF Elisa method was used to determine the anti-angiogenic effect, and the quantitative real-time PCR (qRT-PCR) method on p53, Bax and Bcl-2 mRNA levels were used to evaluate apoptosis. While high amounts of palmitic acid (40.8%), linoleic acid (17.75%) and α-linolenic acid (16.84%) were detected in the SPA, the total amount of unsaturated fatty acid (51.34%) was higher than the total amount of saturated fatty acid (48.66%). SPA displayed the most promising acetylcholinesterase (AChE), butyrylcholinesterase (BuChE) and α-glycosidase (AG) inhibitory activities (AChE: IC

Identifiants

pubmed: 34089947
pii: S0045-2068(21)00409-0
doi: 10.1016/j.bioorg.2021.105032
pii:
doi:

Substances chimiques

Angiogenesis Inhibitors 0
Antineoplastic Agents, Phytogenic 0
Antioxidants 0
Cholinesterase Inhibitors 0
Fatty Acids 0
Glycoside Hydrolase Inhibitors 0
Plant Extracts 0
Acetylcholinesterase EC 3.1.1.7
Butyrylcholinesterase EC 3.1.1.8
alpha-Glucosidases EC 3.2.1.20

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

105032

Informations de copyright

Copyright © 2021 Elsevier Inc. All rights reserved.

Auteurs

Mehmet Kadir Erdogan (M)

Department of Biology, Faculty of Arts and Sciences, Bingol University, 12000 Bingol, Turkey. Electronic address: mkerdogan@bingol.edu.tr.

Ibrahim Halil Gecibesler (I)

Department of Occupational Health and Safety, Faculty of Health Science, Bingol University, 12000 Bingol, Turkey.

Yakup Yapar (Y)

Department of Biology, Faculty of Arts and Sciences, Bingol University, 12000 Bingol, Turkey.

Ramazan Gundogdu (R)

Department of Pharmacy Services, Vocational School of Health Services, Bingol University, 12000 Bingol, Turkey.

Mahinur Kirici (M)

Department of Chemistry, Faculty of Arts and Sciences, Bingol University, 12000 Bingol, Turkey.

Lutfi Behcet (L)

Department of Biology, Faculty of Arts and Sciences, Bingol University, 12000 Bingol, Turkey.

Parham Taslimi (P)

Department of Biotechnology, Faculty of Science, Bartin University, 74100 Bartin, Turkey; Department of Chemistry, Faculty of Science, Istinye University, Istanbul, Turkey. Electronic address: ptaslimi@bartin.edu.tr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH